Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Single Blind Study to Evaluate the Effectiveness and Safety Comparing Niti-S Mira-Cover III Biliary Stent With ComVi Biliary Covered Stent in Patients With Malignant Biliary Obstruction

NCT02460432 is registered in ClinicalTrials.gov with Taewoong Medical Co., Ltd. as lead sponsor.

NCT NCT02460432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02460432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Single Blind Study to Evaluate the Effectiveness and Safety Comparing Niti-S Mira-Cover III Biliary Stent With ComVi Biliary Covered Stent in Patients With Malignant Biliary Obstruction
Lead sponsor
Taewoong Medical Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
December 26, 2016
Enrollment
106 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

biliary neoplasms, biliary obstruction, pancreatic neoplasms